US Stock MarketDetailed Quotes

KNSA Kiniksa Pharmaceuticals International

Watchlist
  • 26.120
  • +0.210+0.81%
Close Jul 26 16:00 ET
  • 26.137
  • +0.017+0.06%
Post 17:05 ET
1.86BMarket Cap-174133P/E (TTM)

Kiniksa Pharmaceuticals International Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Kiniksa Pharmaceuticals International Earnings Date

Currency: USD

Period

Q2 FY2024 Earnings

Jul 23, 2024

Revenue(YoY)

108.63M

+51.99%
EPS(YoY)

-0.06

-128.57%
Analyst Rating

Strong Buy

Jul 26, 2024

Kiniksa Pharmaceuticals International Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 123.964M--
--2024/Q3-- / 111.126M--
Jul 23, 20242024/Q2108.631M / 91.266M--
Apr 23, 20242024/Q179.858M / 78.464M--
Feb 28, 20242023/Q483.395M / 72.272M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 123.964M--
--2024/Q3-- / 111.126M--
Jul 23, 20242024/Q2108.631M / 91.266M--
Apr 23, 20242024/Q179.858M / 78.464M--
Feb 28, 20242023/Q483.395M / 72.272M--

Unlock Free Earnings Estimates

Kiniksa Pharmaceuticals International Earnings Reports

  • Kiniksa Pharmaceuticals International | 10-Q: Quarterly report

    Jul 25 16:16 ET

  • Kiniksa Pharmaceuticals | 10-Q: Quarterly report

    Apr 25 16:22 ET

  • Kiniksa Pharmaceuticals | 10-K: Annual report

    Feb 28 22:32 ET

  • Kiniksa Pharmaceuticals | 10-Q: Q3 2023 Earnings Report

    Nov 2, 2023 16:15 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 26, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg